Queen’s Speech Debate

Full Debate: Read Full Debate
Department: Ministry of Defence
Wednesday 19th May 2021

(3 years, 7 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness Neville-Rolfe Portrait Baroness Neville-Rolfe (Con)
- Hansard - -

I first offer my warm congratulations on a moving, forward-looking and excellent maiden speech by my noble friend Lord Udny-Lister and thank my noble friend Lady Goldie for her excellent introduction. The new programme takes the country forward, building on the Government’s strong electoral showing and the success of the vaccination rollout. Frankly, that makes one proud to be British.

I declare my interests as in the register, first as chair of Crown Agents, a not-for-profit British development company. We have been much involved in the delivery of vaccines, notably to our overseas territories, with Gibraltar now prominent on the green list. Crown Agents has also helped Ukraine to secure non-Russian Covid vaccines and to improve its healthcare system over the last five years. This partnership has led to $60 million of savings in health expenditure and fewer deaths. I believe it is a model that we could replicate elsewhere. To answer the previous speaker, we work with Gavi to deliver vaccines in some of the hardest-to-reach places on earth, bringing to that vital task our knowledge of the chill chain for medicines.

I welcome the creation of the Foreign, Commonwealth and Development Office. It brings together our international efforts, integrating diplomacy and development to achieve greater impact—for example, to address the links between poverty and climate change and to promote English and our cultural heritage across the world, from Shakespeare to the music industry. The cut in development spending is disappointing, but it makes the work of our high commissions and embassies, and the pursuit of value for money, even more important. The Prime Minister’s trade envoys have been given more support by DIT, including my helpful and noble friends Lady Meyer, for Ukraine, Lady Nicholson, for Iraq, Lord Bates, for Ethiopia, Lord Risby, for Lebanon, and many others.

I also support the FCDO and DIT tilt to the Indo-Pacific region. As chair of the UK-ASEAN Business Council, I have been particularly glad to support HMG’s successful efforts to secure post-Brexit dialogue status with ASEAN. It is a region and a trade zone with huge growth potential. Two-way trade was at a peak of £42 billion in 2019. Vietnam, which presided last year, has already attracted much western investment. Brunei is now in the hot seat, and we have been working with it on building back after Covid, with infrastructure, health, energy transition, climate change and a revival of tourism all areas of focus for the 10 ASEAN countries.

That brings me on to trade. For those of us who have studied economics, the theory of comparative advantage is a key tenet. Trade should be encouraged because it benefits both consumers and producers who are productive, creative and effective. It helps developing countries, whose products get squeezed by protectionism. I am a fan of the post-World War II trading system, now in the hands of the WTO, but it struggles to move forward. It is disappointing that the last really significant step forward multilaterally was in 1992, when agriculture was brought properly within the system.

It is regrettable that protectionist forces are found in democracies, which really should know better. Examples can help to bring that home. The former MEP John Longworth was right to call out India; it is a good friend to Britain, but it has failed to abide by tribunal decisions and its treatment of the British telecoms firm Vodafone left much to be desired. The US—which I love, as a home to several family members—failed under President Trump to agree to the appointment of arbitrators at the WTO. Worse, the US has been very slow to agree to export vaccines, even to poor countries desperately in need and even of the AstraZeneca vaccine, mysteriously still not approved by the US regulator. We all know that a US trade agreement will be hard, so it makes sense to start negotiations elsewhere first.

I strongly support the efforts of our Trade Secretary, the energetic Liz Truss, as we move on from Brexit, particularly her efforts on Australia and on CPTPP. Of course, these agreements must bring benefits in exchange for any concessions offered, for example on data and services, and the abolition of discriminatory protectionism on products such as whisky. I hope that the G7 summit in Cornwall will give a new boost to trade.

I have run out of time, but in closing I would like to mention one other troubling example: the apparent US support for a TRIPS waiver on intellectual property rights for Covid vaccines. This proposal has a great number of problems and would really hurt industry. AstraZeneca has been an example to the world in forgoing much of the profit from the production of its Covid vaccine. It is puzzling to suggest that they should be treated so badly.